Received 05/29/2015 review began 05/31/2015 review ended 07/16/2015 published 07/30/2015

HIGHLIGHTS

• who: Report et al. from the (UNIVERSITY) have published the paper: Received 05/29/2015 Review began 05/31/2015 Review ended 07/16/2015 Published 07/30/2015, in the Journal: (JOURNAL) of July/30,/2015
• what: In our experience, denosumab is a newer treatment option for unresectable and recurrent GCTB with good clinical as well as radiological outcomes.
• future: More long-term multicentric studies with large sample population are required in the future to answer these questions.

SUMMARY

Received 05/29/2015 Giant cell tumor of the . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.